Background The first methadone maintenance treatment (MMT) clinic in Tanzania was launched in February 2011 to address an emerging HIV epidemic among people who inject drugs (PWID). We conducted a retrospective cohort study to understand factors associated with linkage to HIV care and explore how a MMT clinic can serve as a platform for integrated HIV care and treatment. Methods This study utilized routine programmatic and clinical data on clients enrolled in methadone at Muhimbili National Hospital from February 2011 to January 2013. Multivariable proportional hazards regression model were used to examine time to initial CD4 count. Results Final analyses included 148 HIV-positive clients, contributing 31.7 person-years. At 30, 60 and 90 days, the probability of CD4 screening was 40% (95% CI: 32–48%), 55% (95% CI: 47%–63%) and 63% (95% CI: 55%–71%), respectively. Clients receiving high methadone doses (≥85mg/day) [aHR:1.68, 95% CI:(1.03, 2.74)] had higher likelihood of CD4 screening than those receiving low doses (<85 mg/day). Clients with primary education or lower [aHR:1.62, 95% CI:(1.05, 2.51)] and self-reported poor health [aHR:1.96, 95% CI:(1.09, 3.51)] were also more likely to obtain CD4 counts. Clients with criminal arrest history [aHR: 0.56, 95% CI: (0.37, 0.85)] were less likely to be linked to care. Among 17 ART-eligible clients (CD4≤200), 12 (71%) initiated treatment, of which 7 (41%) initiated within 90 days. Conclusions Levels of CD4 screening and ART initiation were similar to Sub-Saharan programs caring primarily for non-PWID. Adequate methadone dosing is important in retaining clients to maximize HIV treatment benefits and allow for successful linkage to services.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.